Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:07:16.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.2%
    Check dated 2025-01-12T22:50:21.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:20:39.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has updated the contact details and location information for the study, replacing the previous version with a new section that clarifies how to access this information.
    Difference
    2%
    Check dated 2024-12-07T19:16:19.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    3%
    Check dated 2024-11-23T05:53:15.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    Several key health-related links have been removed, including resources from MedlinePlus, PubMed, and major health organizations like NIH and HHS.
    Difference
    0.3%
    Check dated 2024-11-16T01:29:24.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.